PFKP and ischemic cardiomyopathy: Our findings reveal a positive feedback loop in which hypoxia-induced lactate production promotes PFKP-K688 lactylation, thereby boosting glycolytic output and conferring cytoprotection, which may be a therapeutic target for ischemic cardiomyopathy.